Bynfezia Pen
Payments companies reported to CMS as associated with Bynfezia Pen. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Bynfezia Pen, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Bynfezia Pen
These are the largest totals companies reported as associated with Bynfezia Pen. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| James Michael Bell | Washington, DC | Dermatology | $110.39 |
| Raveena Khanna | Phoenix, AZ | $110.39 | |
| Constance Ediale | Atlanta, GA | Dermatology | $110.39 |
| Hilary Baldwin | Brooklyn, NY | Dermatology | $110.39 |
| Amy Kemp | Lone Tree, CO | Physician Assistant | $22.14 |
| Eric Liu | San Diego, CA | Internal Medicine | $22.14 |
| Laura Periman | Seattle, WA | Ophthalmology | $7.25 |
Prescribed Bynfezia Pen?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.